Oct 14, 2008 - Promius Pharma, LLC, a wholly owned subsidiary of Dr. Reddy's Laboratories (NYSE:RDY) announced the launch of its first product, EpiCeram(R) Skin Barrier Emulsion. EpiCeram(R) Emulsion is a novel prescription therapy for the treatment of atopic dermatitis, a skin disease that affects more than 15 million patients in the United States.
The details can be read here.
No comments:
Post a Comment